Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12609000549224Phase 4Not yet recruiting
Phase 4, randomised, double-blind trial in nausea ((none)) and Vomiting comparing Ondansetron, Metoclopramide and Placebo (3 arms). Primary endpoint: Clinically significant reduction in nausea. Planned start Aug 2009; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12609000549224.